Side-by-side comparison of AI visibility scores, market position, and capabilities
Oakland DLE lithium extraction technology ($318M total, $145M T. Rowe Price Series C); 5th gen 20x production rates with 1-acre = 10,000-acre evaporation pond efficiency and Great Salt Lake/Argentina deployments competing with SLB for lithium supply.
Lilac Solutions is an Oakland, California-based direct lithium extraction (DLE) technology company — backed with over $318 million in total funding including a $145 million Series C led by T. Rowe Price and Presidio Ventures — commercializing a proprietary ion exchange process that extracts lithium from brine resources with 70-98% efficiency using ceramic beads coated with nano-materials, achieving the same lithium output from a 1-acre system that conventional evaporation pond methods require 10,000 acres to produce. Founded in 2016 from CEO Dave Snydacker's PhD research at Northwestern University, Lilac was acquired new CEO Raef Sully (former CEO of Nutrien's $10 billion business unit) in 2024 to lead commercial scaling. In 2025, Lilac unveiled its fifth-generation DLE technology achieving 20x higher lithium production rates and 10,000 operational cycles before replacement — orders of magnitude better than competing technologies. Active projects include the Kachi project in Argentina (with Lake Resources), the Great Salt Lake project in Utah (targeting 3,000 tonnes per year by 2026), and the Neptune project in Germany. Lilac's manufacturing facility in Fernley, Nevada produces the ion exchange beads for commercial deployment. Investors include Breakthrough Energy Ventures.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.